{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:44:12Z","timestamp":1790016252824,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/nchembio.1821","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T15:25:16Z","timestamp":1433172316000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Nontoxic antimicrobials that evade drug resistance"],"prefix":"10.1038","volume":"11","author":[{"given":"Stephen A","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Whitesell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Marchillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Andes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"key":"BFnchembio1821_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li, J. et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589\u2013601 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"BFnchembio1821_CR2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","volume":"369","author":"JE Cortes","year":"2013","unstructured":"Cortes, J.E. et al. A phase 2 trial of ponatinib in Philadelphia chromosome\u2013positive leukemias. N. Engl. J. Med. 369, 1783\u20131796 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnchembio1821_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","volume":"49","author":"D Ellis","year":"2002","unstructured":"Ellis, D. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 49, 7\u201310 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnchembio1821_CR4","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"G Brown","year":"2012","unstructured":"Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv13 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFnchembio1821_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1039\/b820743g","volume":"27","author":"AA Volmer","year":"2010","unstructured":"Volmer, A.A., Szpilman, A.M. & Carreira, E.M. Synthesis and biological evaluation of amphotericin B derivatives. Nat. Prod. Rep. 27, 1329\u20131349 (2010).","journal-title":"Nat. Prod. Rep."},{"key":"BFnchembio1821_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/262698a0","volume":"262","author":"LN Ermishkin","year":"1976","unstructured":"Ermishkin, L.N., Kasumov, K.M. & Potzeluyev, V.M. Single ionic channels induced in lipid bilayers by polyene antibiotics amphotericin B and nystatine. Nature 262, 698\u2013699 (1976).","journal-title":"Nature"},{"key":"BFnchembio1821_CR7","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.1117280109","volume":"109","author":"KC Gray","year":"2012","unstructured":"Gray, K.C. et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. USA 109, 2234\u20132239 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1821_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nchembio.1496","volume":"10","author":"TM Anderson","year":"2014","unstructured":"Anderson, T.M. et al. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat. Chem. Biol. 10, 400\u2013406 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFnchembio1821_CR9","doi-asserted-by":"publisher","first-page":"8488","DOI":"10.1021\/ja403255s","volume":"135","author":"BC Wilcock","year":"2013","unstructured":"Wilcock, B.C., Endo, M.M., Uno, B.E. & Burke, M.D. C2\u2032-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells. J. Am. Chem. Soc. 135, 8488\u20138491 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1821_CR10","doi-asserted-by":"publisher","first-page":"e1000939","DOI":"10.1371\/journal.ppat.1000939","volume":"6","author":"Y-Q Zhang","year":"2010","unstructured":"Zhang, Y.-Q. et al. Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. PLoS Pathog. 6, e1000939 (2010).","journal-title":"PLoS Pathog."},{"key":"BFnchembio1821_CR11","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1091\/mbc.e02-04-0186","volume":"13","author":"A Heese-Peck","year":"2002","unstructured":"Heese-Peck, A. et al. Multiple functions of sterols in yeast endocytosis. Mol. Biol. Cell 13, 2664\u20132680 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"BFnchembio1821_CR12","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1093\/emboj\/20.15.4035","volume":"20","author":"M Kato","year":"2001","unstructured":"Kato, M. & Wickner, W. Ergosterol is required for the Sec18\/ATP-dependent priming step of homotypic vacuole fusion. EMBO J. 20, 4035\u20134040 (2001).","journal-title":"EMBO J."},{"key":"BFnchembio1821_CR13","doi-asserted-by":"publisher","first-page":"30224","DOI":"10.1074\/jbc.M110.123554","volume":"285","author":"C Klose","year":"2010","unstructured":"Klose, C. et al. Yeast lipids can phase-separate into micrometer-scale membrane domains. J. Biol. Chem. 285, 30224\u201330232 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1821_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1083\/jcb.200705076","volume":"180","author":"H Jin","year":"2008","unstructured":"Jin, H., McCaffery, J.M. & Grote, E. Ergosterol promotes pheromone signaling and plasma membrane fusion in mating yeast. J. Cell Biol. 180, 813\u2013826 (2008).","journal-title":"J. Cell Biol."},{"key":"BFnchembio1821_CR15","doi-asserted-by":"publisher","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"BM Vincent","year":"2013","unstructured":"Vincent, B.M., Lancaster, A.K., Scherz-Shouval, R., Whitesell, L. & Lindquist, S. Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol. 11, e1001692 (2013).","journal-title":"PLoS Biol."},{"key":"BFnchembio1821_CR16","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1073\/pnas.1015023108","volume":"108","author":"DS Palacios","year":"2011","unstructured":"Palacios, D.S., Dailey, I., Siebert, D.M., Wilcock, B.C. & Burke, M.D. Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities. Proc. Natl. Acad. Sci. USA 108, 6733\u20136738 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1821_CR17","doi-asserted-by":"publisher","first-page":"18266","DOI":"10.1021\/ja1074344","volume":"132","author":"A Neumann","year":"2010","unstructured":"Neumann, A., Baginski, M. & Czub, J. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets. J. Am. Chem. Soc. 132, 18266\u201318272 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1821_CR18","doi-asserted-by":"publisher","first-page":"10667","DOI":"10.1021\/ja051597r","volume":"127","author":"N Matsumori","year":"2005","unstructured":"Matsumori, N., Sawada, Y. & Murata, M. Mycosamine orientation of amphotericin B controlling interaction with ergosterol: sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge. J. Am. Chem. Soc. 127, 10667\u201310675 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1821_CR19","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1021\/cg2017227","volume":"12","author":"KN Jarzembska","year":"2012","unstructured":"Jarzembska, K.N. et al. Controlled crystallization, structure, and molecular properties of iodoacetylamphotericin B. Cryst. Growth Des. 12, 2336\u20132345 (2012).","journal-title":"Cryst. Growth Des."},{"key":"BFnchembio1821_CR20","doi-asserted-by":"publisher","first-page":"9582","DOI":"10.1073\/pnas.0801261105","volume":"105","author":"M Neant-Fery","year":"2008","unstructured":"Neant-Fery, M. et al. Molecular basis for the thiol sensitivity of insulin-degrading enzyme. Proc. Natl. Acad. Sci. USA 105, 9582\u20139587 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1821_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nchembio.663","volume":"7","author":"KC Duggan","year":"2011","unstructured":"Duggan, K.C. et al. (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat. Chem. Biol. 7, 803\u2013809 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"BFnchembio1821_CR22","unstructured":"MacPherson, D.T. et al. in Recent Advances in the Chemistry of Anti-infective Agents Vol. 119, 205\u2013222 (Royal Society of Chemistry, 1993)."},{"key":"BFnchembio1821_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2007.11.008","volume":"15","author":"P Power","year":"2008","unstructured":"Power, P. et al. Engineered synthesis of 7-oxo- and 15-deoxy-15-oxo-amphotericins: insights into structure-activity relationships in polyene antibiotics. Chem. Biol. 15, 78\u201386 (2008).","journal-title":"Chem. Biol."},{"key":"BFnchembio1821_CR24","doi-asserted-by":"publisher","first-page":"34420","DOI":"10.1074\/jbc.M506689200","volume":"280","author":"M Carmody","year":"2005","unstructured":"Carmody, M. et al. Biosynthesis of amphotericin derivatives lacking exocyclic carboxyl groups. J. Biol. Chem. 280, 34420\u201334426 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1821_CR25","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.chembiol.2003.12.001","volume":"10","author":"B Byrne","year":"2003","unstructured":"Byrne, B., Carmody, M., Gibson, E., Rawlings, B. & Caffrey, P. Biosynthesis of deoxyamphotericins and deoxyamphoteronolides by engineered strains of Streptomyces nodosus. Chem. Biol. 10, 1215\u20131224 (2003).","journal-title":"Chem. Biol."},{"key":"BFnchembio1821_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1055\/s-1988-27592","volume":"1988","author":"H Maeda","year":"1988","unstructured":"Maeda, H., Suzuki, M., Sugano, H. & Matsumoto, K. A facile synthesis of (S)-isoserine from (S)-malic acid. Synthesis 1988, 401\u2013402 (1988).","journal-title":"Synthesis"},{"key":"BFnchembio1821_CR27","doi-asserted-by":"publisher","first-page":"13804","DOI":"10.1021\/ja075739o","volume":"129","author":"DS Palacios","year":"2007","unstructured":"Palacios, D.S., Anderson, T.M. & Burke, M.D.A. Post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity. J. Am. Chem. Soc. 129, 13804\u201313805 (2007).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1821_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.7164\/antibiotics.25.261","volume":"25","author":"DP Bonner","year":"1972","unstructured":"Bonner, D.P., Mechlinski, W. & Schaffner, C.P. Polyene macrolide derivatives. 3. Biological properties of polyene macrolide ester salts. J. Antibiot. 25, 261\u2013262 (1972).","journal-title":"J. Antibiot."},{"key":"BFnchembio1821_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1128\/AAC.10.4.687","volume":"10","author":"GR Keim","year":"1976","unstructured":"Keim, G.R. et al. Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats, and dogs. Antimicrob. Agents Chemother. 10, 687\u2013690 (1976).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR30","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1128\/AAC.00270-13","volume":"57","author":"AN Tevyashova","year":"2013","unstructured":"Tevyashova, A.N. et al. Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. Antimicrob. Agents Chemother. 57, 3815\u20133822 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR31","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/chem.200701237","volume":"14","author":"V Paquet","year":"2008","unstructured":"Paquet, V., Volmer, A.A. & Carreira, E.M. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B. Chemistry 14, 2465\u20132481 (2008).","journal-title":"Chemistry"},{"key":"BFnchembio1821_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","volume":"74","author":"M Pfaller","year":"2012","unstructured":"Pfaller, M. et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008. Diagn. Microbiol. Infect. Dis. 74, 323\u2013331 (2012).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"BFnchembio1821_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1128\/AAC.44.1.143-149.2000","volume":"44","author":"MC Cruz","year":"2000","unstructured":"Cruz, M.C. et al. Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob. Agents Chemother. 44, 143\u2013149 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/AAC.01279-12","volume":"57","author":"AJ Lepak","year":"2013","unstructured":"Lepak, A.J., Marchillo, K., VanHecker, J. & Andes, D.R. Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 57, 579\u2013585 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1039\/C0MB00146E","volume":"7","author":"JK Ellis","year":"2011","unstructured":"Ellis, J.K. et al. Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system. Mol. Biosyst. 7, 247\u2013257 (2011).","journal-title":"Mol. Biosyst."},{"key":"BFnchembio1821_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/ajkd.2000.8967","volume":"36","author":"RA Zager","year":"2000","unstructured":"Zager, R.A. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content. Am. J. Kidney Dis. 36, 238\u2013249 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnchembio1821_CR37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1128\/AAC.45.3.922-926.2001","volume":"45","author":"D Andes","year":"2001","unstructured":"Andes, D., Stamsted, T. & Conklin, R. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model. Antimicrob. Agents Chemother. 45, 922\u2013926 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR38","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller, M.A. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125, S3\u2013S13 (2012).","journal-title":"Am. J. Med."},{"key":"BFnchembio1821_CR39","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","volume":"47","author":"D Sanglard","year":"2003","unstructured":"Sanglard, D., Ischer, F., Parkinson, T., Falconer, D. & Bille, J. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47, 2404\u20132412 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR40","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/JCM.00248-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller, M.A. et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J. Clin. Microbiol. 50, 2040\u20132046 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"BFnchembio1821_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fgene.2014.00160","volume":"5","author":"JP Pinto","year":"2014","unstructured":"Pinto, J.P., Machado, R., Xavier, J.G. & Futschik, M.E. Targeting molecular networks for drug research. Front. Genet. 5, 160 (2014).","journal-title":"Front. Genet."},{"key":"BFnchembio1821_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1021\/op300031r","volume":"16","author":"P Grongsaard","year":"2012","unstructured":"Grongsaard, P. et al. Convergent, kilogram scale synthesis of an Akt kinase inhibitor. Org. Process Res. Dev. 16, 1069\u20131081 (2012).","journal-title":"Org. Process Res. Dev."},{"key":"BFnchembio1821_CR43","unstructured":"Dailey, I. Synthesis and Function of the Conserved Motif of Mycosamine Containing Polyene Macrolides. PhD thesis,University of Illinois at Urbana-Champaign, (2012)."},{"key":"BFnchembio1821_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1128\/AAC.15.5.716","volume":"15","author":"J Kotler-Brajtburg","year":"1979","unstructured":"Kotler-Brajtburg, J. et al. Classification of polyene antibiotics according to chemical structure and biological effects. Antimicrob. Agents Chemother. 15, 716\u2013722 (1979).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR45","first-page":"339","volume":"29","author":"M Moonis","year":"1992","unstructured":"Moonis, M., Ahmad, I. & Bachhawat, B.K. Liposomal hamycin in the control of experimental aspergillosis in mice\u2014relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin. Indian J. Biochem. Biophys. 29, 339\u2013345 (1992).","journal-title":"Indian J. Biochem. Biophys."},{"key":"BFnchembio1821_CR46","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1126\/science.1129818","volume":"313","author":"HE Hasper","year":"2006","unstructured":"Hasper, H.E. et al. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636\u20131637 (2006).","journal-title":"Science"},{"key":"BFnchembio1821_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L.L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015).","journal-title":"Nature"},{"key":"BFnchembio1821_CR48","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1185723","volume":"328","author":"T Schneider","year":"2010","unstructured":"Schneider, T. et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 328, 1168\u20131172 (2010).","journal-title":"Science"},{"key":"BFnchembio1821_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nature13419","volume":"510","author":"A Laganowsky","year":"2014","unstructured":"Laganowsky, A. et al. Membrane proteins bind lipids selectively to modulate their structure and function. Nature 510, 172\u2013175 (2014).","journal-title":"Nature"},{"key":"BFnchembio1821_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mas.20342","volume":"31","author":"X Han","year":"2012","unstructured":"Han, X., Yang, K. & Gross, R.W. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom. Rev. 31, 134\u2013178 (2012).","journal-title":"Mass Spectrom. Rev."},{"key":"BFnchembio1821_CR51","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/om9503712","volume":"15","author":"AB Pangborn","year":"1996","unstructured":"Pangborn, A.B., Giardello, M.A., Grubbs, R.H., Rosen, R.K. & Timmers, F.J. Safe and convenient procedure for solvent purification. Organometallics 15, 1518\u20131520 (1996).","journal-title":"Organometallics"},{"key":"BFnchembio1821_CR52","unstructured":"Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed., CLSI document M27\u2013A3 (Clinical and Laboratory Standards Institute, Wayne, PA, 2008)."},{"key":"BFnchembio1821_CR53","unstructured":"Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd edn. CLSI document M38\u2013A2 (Clinical Laboratory Standards Institute, Wayne, PA, 2007)."},{"key":"BFnchembio1821_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/pst.426","volume":"10","author":"JL Sebaugh","year":"2011","unstructured":"Sebaugh, J.L. Guidelines for accurate EC50\/IC50 estimation. Pharm. Stat. 10, 128\u2013134 (2011).","journal-title":"Pharm. Stat."},{"key":"BFnchembio1821_CR55","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1128\/AAC.43.9.2116","volume":"43","author":"D Andes","year":"1999","unstructured":"Andes, D. & van Ogtrop, M. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model. Antimicrob. Agents Chemother. 43, 2116\u20132120 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1821_CR56","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1128\/AAC.44.4.938-942.2000","volume":"44","author":"D Andes","year":"2000","unstructured":"Andes, D. & van Ogtrop, M. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model. Antimicrob. Agents Chemother. 44, 938\u2013942 (2000).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1821","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:38:55Z","timestamp":1684424335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFnchembio1821"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.1821","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725528151.793507812","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725528151.793517281","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,1]]},"assertion":[{"value":"29 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Illinois has filed patents on compounds and chemistry reported herein. These have been licensed to REVOLUTION Medicines, a company for which M.D.B. is a founder.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}